DALLAS (PRWEB) FEBRUARY 11, 2020
CTL Amedica Corporation has been granted an official patent from the United States Patent and Trademark Office for a screw offset blocking mechanism, which has been thoughtfully designed for and implemented in the company’s newly released MONET™ Anterior Cervical Fusion System. CTL Amedica plans to implement the robust blocking mechanism in future cervical and lumbar plating systems. The US Patent for the offset blocking mechanism – number 10,543,101 – was issued Jan. 28, 2020.
“Cervical surgeries make up more than half of all spine surgeries worldwide, and integrated technologies continue to flourish throughout the entire orthopedic implant sector, so we’re particularly pleased to announce this new patent. The blocking technology can be utilized in current and future products and may have licensing possibilities down-the-road,” says Daniel Chon, CTL Amedica Corporation president and CEO. “Due to its fundamental application throughout the entire orthopedic fixation arena, screw blocking technology is one of the most competitive and intellectually protected areas of medical device development today. CTL Amedica’s newly patented technology is one of many core development investments our company is making, and is also a testament to our team’s determination and dedication to excellence.”
The cervical area refers to the seven vertebral segments in the spine that make up the neck and connect the brain to the spinal cord. The newly patented, offset screw blocking mechanism can be found in the FDA-cleared, integrated MONET™ Anterior Cervical Fusion System, which features both titanium and PEEK cage options. The MONET™ also features integrated, anterior plating options, including low-profile, four-screw configurations, as well as zero-profile, two-screw assemblies. These construct options provide surgeons with the true intra-operative flexibility required to accommodate each patient’s individual anatomy.
CTL Amedica Corporation is a forward-thinking medical device design, development and manufacturing company. CTL Amedica maintains a Texas-based headquarters and in-house manufacturing facility, along with a Pennsylvania-based R&D Center of Excellence. A leader in the medical device technology and biomaterials space, CTL Amedica provides a full line of cervical, thoracic and lumbar fusion and fixations products. In addition, it is the world’s exclusive provider of silicon nitride spine products. Silicon nitride demonstrates unique bacteriostatic properties, provides superior imaging across all modalities and promotes an enhanced osteogenic response. For more information, visit https://www.ctlamedica.com/.